NeuroOne Medical Technologies (NASDAQ:NMTC) Trading Down 5.8% – Here’s Why

NeuroOne Medical Technologies Co. (NASDAQ:NMTC)’s share price fell 5.8% during trading on Monday . The stock traded as low as $0.94 and last traded at $0.97. 128,628 shares were traded during trading, a decline of 19% from the average session volume of 158,317 shares. The stock had previously closed at $1.03.

NeuroOne Medical Technologies Stock Performance

The stock has a market cap of $29.94 million, a PE ratio of -3.73 and a beta of 0.48. The business has a 50 day moving average price of $1.08 and a two-hundred day moving average price of $0.94.

NeuroOne Medical Technologies (NASDAQ:NMTC) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.06 EPS for the quarter. NeuroOne Medical Technologies had a negative return on equity of 270.70% and a negative net margin of 82.17%.

Institutional Trading of NeuroOne Medical Technologies

A number of large investors have recently added to or reduced their stakes in NMTC. Geode Capital Management LLC raised its stake in shares of NeuroOne Medical Technologies by 9.8% in the fourth quarter. Geode Capital Management LLC now owns 311,659 shares of the company’s stock valued at $257,000 after buying an additional 27,804 shares during the period. Jane Street Group LLC purchased a new stake in NeuroOne Medical Technologies in the 4th quarter worth about $33,000. Finally, XTX Topco Ltd bought a new stake in NeuroOne Medical Technologies in the 3rd quarter valued at about $26,000. Hedge funds and other institutional investors own 16.07% of the company’s stock.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.